ZC-B
| Clinical data | |
|---|---|
| Other names | 3-(4-Bromo-2,5-dimethoxyphenyl)azetidine; 2C-B-AZET; 2C-B-Azet |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| UNII | |
| Chemical and physical data | |
| Formula | C11H14BrNO2 |
| Molar mass | 272.142 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
ZC-B, also known as 3-(4-bromo-2,5-dimethoxyphenyl)azetidine or as 2C-B-AZET, is a phenethylamine derivative which acts as a serotonin receptor agonist selective for the 5-HT2 subtypes, with an EC50 of 1.6 nM at 5-HT2A, vs 5.8 nM at 5-HT2C. It is structurally related to the psychedelic phenethylamines 2C-B and DOB, but with the amine side chain conformationally restricted as an azetidine ring.